Literature DB >> 175027

Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis.

G W Bornkamm, H Stein, K Lennert, F Rüggeberg, H Bartels, H zur Hausen.   

Abstract

Various biopsies from different European malignant lymphomas, two biopsies from nasopharyngeal carcinomas, and material from non-neoplastic lymph nodes were assayed for the presence of Epstein-Barr virus (EBV) DNA by nucleic acid hybridization. Reassociation kinetics of in vitro-labelled EBV DNA were studied in the presence of tumor DNA. The lymphomas tested included among others follicular lymphomas, germinocytomas, immunoblastic lymphomas and lymphoplasmacytoid immunocytomas. Epstein-Barr viral DNA was demonstrated within the two nasopharyngeal carcinoma biopsies as expected. A histologically typical Burkitt lymphoma as well as an immunoblastic lymphadenopathy with excessive plasmacytosis also contained EBV-DNA. The Burkitt biopsy revealed about 15 EBV genome equivalents per cell. Antibodies against EBV-specific antigens were highly elevated in the serum of this patient. The material of the patient with immunoblastic lymphadenopathy contained 2-3 EBV genome equivalents per cell.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175027     DOI: 10.1002/ijc.2910170205

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Tumor initiators and promoters in the induction of Epstein-Barr virus.

Authors:  H zur Hausen; G W Bornkamm; R Schmidt; E Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Physiological and biochemical contributions to the taxonomy of the genus Chlorella. XI. DNA hybridization.

Authors:  W Kerfin; E Kessler
Journal:  Arch Microbiol       Date:  1978-01-23       Impact factor: 2.552

3.  Angioimmunoblastic lymphadenopathy type of T-cell lymphoma and angioimmunoblastic lymphadenopathy: a clinicopathological and molecular biological study of 13 Chinese patients using polymerase chain reaction and paraffin-embedded tissues.

Authors:  J Lorenzen; G Li; M Zhao-Höhn; C Wintzer; R Fischer; M L Hansmann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Epstein-Barr virus-positive Burkitt's lymphoma in a German woman during pregnancy.

Authors:  G W Bornkamm; B Kaduk; G Kachel; U Schneider; K O Fresen; G Schwanitz; P Hermanek
Journal:  Blut       Date:  1980-03

Review 5.  Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

Authors:  Lindsay C George; Martin Rowe; Christopher P Fox
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

6.  Histological, immunohistological and autopsy findings in lymphogranulomatosis X (including angio-immunoblastic lymphadenopathy).

Authors:  H Knecht; E W Schwarze; K Lennert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

7.  Angioimmunoblastic lymphadenopathy after infectious mononucleosis.

Authors:  J M Seigneurin; J Mingat; G M Lenoir; P Couderc; M Micoud
Journal:  Br Med J (Clin Res Ed)       Date:  1981-05-16

8.  A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas.

Authors:  S J Hamilton-Dutoit; G Pallesen
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

9.  Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders.

Authors:  B Z Katz; U Saini
Journal:  Am J Pathol       Date:  1992-05       Impact factor: 4.307

10.  Lymphoma in cotton-top marmosets after inoculation with Epstein-Barr virus: tumor incidence, histologic spectrum antibody responses, demonstration of viral DNA, and characterization of viruses.

Authors:  G Miller; T Shope; D Coope; L Waters; J Pagano; G Bornkamn; W Henle
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.